<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2283">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01887899</url>
  </required_header>
  <id_info>
    <org_study_id>Plasticity in Alzheimer's</org_study_id>
    <nct_id>NCT01887899</nct_id>
  </id_info>
  <brief_title>Influence of tDCS on Cortical Plasticity in Patients With Dementia of the Alzheimer Type</brief_title>
  <official_title>Influence of Transcranial Direct-current Stimulation on Cortical Plasticity in Patients With Dementia of the Alzheimer Type</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate whether the anodal transcranial direct current&#xD;
      stimulation (tDCS) over the primary motor cortex (M1) in patients with dementia of the&#xD;
      Alzheimer type (DAT) leads to an increase in cortical plasticity (change in motor evoked&#xD;
      potentials (MEP) in mV).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Not funded&#xD;
  </why_stopped>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the anodal transcranial direct current stimulation over the primary motor cortex (M1) in patients with dementia of Alzheimer type (DAT)</measure>
    <time_frame>1 week</time_frame>
    <description>to investigate whether the anodal transcranial direct current stimulation over the primary motor cortex (M1) in patients with dementia of Alzheimer type (DAT) increases cortical plasticity (measured via motor evoked potentials) compared to a sham stimulation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>tDCS effects on central cholinergic activity in patients with DAT</measure>
    <time_frame>1 week</time_frame>
    <description>to investigate whether the anodal transcranial direct current stimulation affect central cholinergic activity (measured via a TMS-protocol) in patients with dementia of Alzheimer type (DAT) compared to a sham stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tDCS effects on learning</measure>
    <time_frame>1 week</time_frame>
    <description>tDCS-induced changes in learning success (performance in a motor learning paradigm in patients with DAT after tDCS vs. sham stimulation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MR elastography</measure>
    <time_frame>1 week</time_frame>
    <description>Comparison of viscoelastic parameters in cerebral MR elastography in patients with DAT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>genetic polymorphism, ApoE4</measure>
    <time_frame>once</time_frame>
    <description>optional assessment of genetic Apo4 epsilon status for assessment of differences in cortical plasticity and elasticity between Apo4 epsilon positive and negative participants</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Dementia of Type Alzheimer</condition>
  <arm_group>
    <arm_group_label>transcranial direct current stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sham stimulation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation</intervention_name>
    <arm_group_label>transcranial direct current stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham stimulation</intervention_name>
    <arm_group_label>sham stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Right-handed according to the Oldfield Händigkeits inventory (lateralization index&gt;&#xD;
             70) (1971)&#xD;
&#xD;
          -  Cognitive impairment, which corresponds to a mild to moderate DAT&#xD;
&#xD;
          -  No treatment with AChE inhibitors, or existing stable treatment with AChE inhibitors&#xD;
             for over 3 months&#xD;
&#xD;
          -  No motor impairments relevant to everyday life&#xD;
&#xD;
          -  Age 50 to 80 years&#xD;
&#xD;
          -  Existing Insurance certificate&#xD;
&#xD;
          -  Existing informed consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Severe neurological / psychiatric or pre-existing internist conditions because&#xD;
             additional cognitive deficits are expected&#xD;
&#xD;
          -  Epilepsy, epileptic seizure in medical history&#xD;
&#xD;
          -  Cognitive deficit (MMSE &lt;20)&#xD;
&#xD;
          -  Depressive episode (Beck Depression Inventory (BDI)&gt; 12)&#xD;
&#xD;
          -  intake of centrally active drugs &lt;3 months, particularly acetylcholinesterase&#xD;
             inhibitors&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Pacemaker (contraindication for MRI)&#xD;
&#xD;
          -  Other metal parts in the body (contraindication for MRI)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Klinik und Poliklinik für Neurologie, Charité Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>June 25, 2013</study_first_submitted>
  <study_first_submitted_qc>June 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2013</study_first_posted>
  <last_update_submitted>May 12, 2021</last_update_submitted>
  <last_update_submitted_qc>May 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Agnes Flöel</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>cortical plasticity</keyword>
  <keyword>transcranial direct current stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

